Roche First-Quarter Sales Drop, Hurt by Copycats and Currencies

Roche Holding AG reported a first-quarter sales decline, primarily due to competition from generic drugs (copycats) and adverse currency effects. The company's headquarters in Basel, Switzerland, was highlighted in the report.